Related Experiment Videos
Hydroxyamphetamine mydriasis in Horner's syndrome
S A Cremer1, H S Thompson, K B Digre
1Department of Ophthalmology, University of Iowa, Iowa City.
American Journal of Ophthalmology
|July 15, 1990
Summary
Hydroxyamphetamine hydrobromide 1% effectively differentiates preganglionic from postganglionic lesions in Horner's syndrome. Pupillary dilation patterns reveal the lesion location, aiding diagnosis.
Area of Science:
- Ophthalmology
- Neurology
- Pharmacology
Background:
- Horner's syndrome results from damage to the oculosympathetic pathway.
- Distinguishing preganglionic from postganglionic lesions is crucial for diagnosis and management.
- Accurate localization of lesions aids in identifying underlying causes.
Purpose of the Study:
- To evaluate hydroxyamphetamine hydrobromide 1% (Paredrine) as a diagnostic tool.
- To differentiate preganglionic from postganglionic lesions in Horner's syndrome.
- To assess pupillary dilation as a measure of hydroxyamphetamine's effect.
Main Methods:
- Studied 54 patients diagnosed with Horner's syndrome.
- Administered hydroxyamphetamine hydrobromide 1% to induce mydriasis.
- Measured and compared pupillary dilation between affected and unaffected eyes.
Main Results:
- Patients with postganglionic lesions showed reduced pupillary dilation on the affected side.
- Patients with preganglionic lesions exhibited greater pupillary dilation on the affected side.
- Established the probability of postganglionic lesions based on pupillary dilation differences.
Conclusions:
- Hydroxyamphetamine hydrobromide 1% is effective in distinguishing preganglionic from postganglionic lesions in Horner's syndrome.
- Pupillary response to hydroxyamphetamine aids in localizing oculosympathetic pathway damage.
- This pharmacological test provides valuable diagnostic information for Horner's syndrome.